HSBC Holdings
GNMK

HSBC Holdings’s GenMark Diagnostics, Inc GNMK Stock Holding History

HSBC Holdings’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,103
Closed -$163K – 2942
2020
Q2 		$163K Buy
+11,103
New +$113K ﹤0.01% 2425
2020
Q1 		– Sell
-41,277
Closed -$197K – 3148
2019
Q4 		$197K Sell
41,277
-36,561
-47% -$202K ﹤0.01% 2821
2019
Q3 		$472K Buy
+77,838
New +$486K ﹤0.01% 2371

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

HSBC Holdings's GNMK Position: Q3 2020 in Review

HSBC Holdings sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2020, closing a stake of 11,103 shares — an estimated $163K sold.

HSBC Holdings first reported a position in GNMK in Q3 2019 and held it in 3 quarters. The position peaked at $472K in Q3 2019. 163 funds tracked by Wall St. Rank hold GNMK as of Q3 2020.

  • HSBC Holdings reported no remaining GenMark Diagnostics, Inc position as of Q3 2020 after selling out during the quarter.
  • HSBC Holdings sold 11,103 GenMark Diagnostics, Inc shares in Q3 2020, an estimated $163K.
  • HSBC Holdings first reported a position in GenMark Diagnostics, Inc in Q3 2019 and held it in 3 quarters.
  • HSBC Holdings's GenMark Diagnostics, Inc position peaked at $472K in Q3 2019.
  • 163 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2020.

Based on HSBC Holdings's 13F filing for Q3 2020, filed 12 Nov 2020.